Les Meilleurs doctors pour le traitement de cancer de l'estomac stade 2 en Israël - TOP-19 des médecins

Le Dr Pelles Sharon est spécialisée dans la chirurgie du cancer de l'estomac au centre médical Sourasky (Ichilov), avec une expertise dans les traitements avancés tels que le HIPEC et l'immunothérapie.

• Réaliser des chirurgies complexes du cancer de l'estomac, y compris la procédure de Whipple
• Pratiquer la chimiothérapie intrapéritonéale hyperthermique (HIPEC) pour les cas agressifs
• Proposer des options d'immunothérapie comme le Keytruda pour un traitement ciblé
• Diriger des recherches cliniques sur l'attitude des patients oncologiques vis-à-vis des essais cliniques

Le professeur Merimsky dirige l'unité d'oncologie des tissus mous et des os au centre médical Sourasky, fort de décennies d'expérience spécialisée dans le cancer de l'estomac.

• Professeur associé d'oncologie à l'université de Tel-Aviv
• Formation de fellowship à l'Institut Gustave Roussy à Paris
• Membre de la faculté de sarcome de l'ESMO et de l'ASCO
• Auteur de nombreuses publications sur les résultats du traitement du cancer

Il dirige un centre dédié à la prévention du cancer au centre médical Sourasky de Tel Aviv, se concentrant sur le dépistage précoce et le traitement des cancers gastro-intestinaux.

• Plus de 30 ans d'expérience spécialisée en oncologie du tractus gastro-intestinal
• Chef du Centre Intégré de Prévention du Cancer – l'un des principaux établissements de lutte contre le cancer en Israël
• Auteur de plus de 300 articles de recherche sur la prévention du cancer et la thérapie génique
• Réaliser des travaux de recherche importants au NewYork-Presbyterian Center aux États-Unis
• Membre de sociétés internationales clés telles que la European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

À la tête de l'Initiative nationale israélienne de médecine génomique, le Dr Raphael se spécialise dans le profilage génomique avancé pour le traitement personnalisé du cancer de l'estomac au centre médical Sourasky.

• Maître de conférences en oncologie médicale avec une vaste expérience dans la direction d'essais cliniques
• Expert en biopsies liquides et en profilage génomique complet
• Investigateur principal (PI) pour de multiples études innovantes en immunothérapie et chimiothérapie
• Membre de l'ESMO, de l'IASLC et d'autres sociétés d'oncologie prestigieuses
• Lauréat de plusieurs prix d'excellence en enseignement et en recherche

Le Dr Wolf dirige le département d'oncologie médicale du centre médical Sourasky – un hôpital universitaire israélien majeur doté d'une grande expertise dans les soins complexes contre le cancer.

• Se spécialiser en oncologie médicale et en médecine interne
• Parler couramment l'anglais pour les patients internationaux
• Détenir un diplôme de l'université Ben Gourion
• Acquérir une vaste expérience clinique dans les unités médicales de l'armée

Le Dr Stepfansky dirige l'unité d'hospitalisation d'oncologie du principal hôpital de Tel Aviv, Ichilov, et participe à des essais cliniques pour les traitements les plus récents.

• Plus de 20 ans d'expérience en médecine interne et en oncologie
• Diriger les soins oncologiques en milieu hospitalier au centre médical Sourasky
• Investigateur principal pour les études cliniques de phases 1 à 3
• Suivre une formation approfondie à l'hôpital Ichilov de Tel Aviv

Dirige le département de chirurgie colorectal au centre médical Sourasky et est un spécialiste de premier plan pour les interventions abdominales complexes.

• Plus de 20 ans d'expérience en chirurgie
• Expert en chirurgie ouverte et mini-invasive
• Spécialisé dans les techniques avancées comme l'intervention de Whipple

Le Dr Alexander Beny dirige le service des tumeurs malignes gastro-intestinales au centre médical Rambam, se spécialisant dans le traitement du cancer de l'estomac.

• Oncologue certifié possédant une vaste formation en oncologie médicale et en radiothérapie
• Directeur du service des tumeurs malignes gastro-intestinales au centre médical Rambam
• Parle couramment l'anglais et l'hébreu pour les patients internationaux
• Formation spécialisée complétée dans les techniques modernes de curiethérapie

Le professeur Tamar Jablonski-Perec dirige l'oncologie au centre médical Hadassah, après avoir été formée au Sloan-Kettering Cancer Center à New York.

• Diriger l'Institut d'oncologie depuis 1994
• Se spécialiser dans le traitement du cancer du sein
• Professeur au département d'oncologie de l'Université hébraïque
• Membre de communautés internationales de lutte contre le cancer
• Lauréate d'une bourse de l'école de médecine Hadassah

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.